Literature DB >> 8681635

Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation. Advance care planning and outcomes.

A H Moss1, E A Oppenheimer, P Casey, P A Cazzolli, R P Roos, C B Stocking, M Siegler.   

Abstract

OBJECTIVE: To examine advance care planning and outcomes of patients with amyotrophic lateral sclerosis (ALS) receiving long-term mechanical ventilation (LTMV).
DESIGN: Case series.
SETTING: Population-based study in homes and chronic care facilities in four states, and Home Ventilator Program of California Kaiser Permanente. PATIENTS: Seventy-five ALS patients receiving LTMV were identified; 11 died prior to interview, and 6 were totally locked in; 50 of 58 (86%) who were able to communicate consented to structured interviews, of whom 36 lived at home and 14 in an institution.
RESULTS: Thirty-eight patients (76%) had completed advance directives, and 96% wanted them. Thirty-eight patients wished to stop LTMV in certain circumstances, of whom 30 had completed advance directives. Those who had completed advance directives were more likely to have communicated their preference, to stop LTMV to family and physician than those who had not (76 vs 29%; p = 0.05). Patients living at home rated their quality of life on a 10-point scale better than those in an institution (7.2 vs 5.6; p = 0.0052), and their yearly expenses were less ($136,560 vs $366,852; p = 0.0018).
CONCLUSIONS: Most ALS patients receiving LTMV would want to stop it under certain circumstances, and the process of advance care planning enhances communication of patient preferences to family and physicians. Home-based LTMV is less costly and associated with greater patient satisfaction.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  1996        PMID: 8681635     DOI: 10.1378/chest.110.1.249

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

Review 1.  Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease.

Authors:  M I Polkey; R A Lyall; A C Davidson; P N Leigh; J Moxham
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 2.  Ethics and decision making in end stage lung disease.

Authors:  A K Simonds
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 3.  Management of motor neurone disease.

Authors:  R S Howard; R W Orrell
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

4.  Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline.

Authors:  Douglas A McKim; Jeremy Road; Monica Avendano; Steve Abdool; Fabien Cote; Nigel Duguid; Janet Fraser; Fracois Maltais; Debra L Morrison; Colleen O'Connell; Basil J Petrof; Karen Rimmer; Robert Skomro
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

5.  Advance care planning for patients with amyotrophic lateral sclerosis.

Authors:  Benjamin H Levi; Zachary Simmons; Courtney Hanna; Allyson Brothers; Erik Lehman; Elana Farace; Megan Bain; Renee Stewart; Michael J Green
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-03-05       Impact factor: 4.092

Review 6.  Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.

Authors:  Alan Moore; Carolyn A Young; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

7.  Family health care decision making and self-efficacy with patients with ALS at the end of life.

Authors:  Marie T Nolan; Joan Kub; Mark T Hughes; Peter B Terry; Alan B Astrow; Cynthia A Carbo; Richard E Thompson; Lora Clawson; Kenneth Texeira; Daniel P Sulmasy
Journal:  Palliat Support Care       Date:  2008-09

8.  Offline Identification of Imagined Speed of Wrist Movements in Paralyzed ALS Patients from Single-Trial EEG.

Authors:  Ying Gu; Dario Farina; Ander Ramos Murguialday; Kim Dremstrup; Pedro Montoya; Niels Birbaumer
Journal:  Front Neurosci       Date:  2009-08-10       Impact factor: 4.677

9.  Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy.

Authors:  Karsten Schepelmann; Yaroslav Winter; Annika E Spottke; Detlef Claus; Christoph Grothe; Rolf Schröder; Dieter Heuss; Stefan Vielhaber; Veit Mylius; Reinhard Kiefer; Bertold Schrank; Wolfgang H Oertel; Richard Dodel
Journal:  J Neurol       Date:  2009-07-24       Impact factor: 4.849

Review 10.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.